Feed / TDOC

Teladoc Health, Inc.

TDOC

Healthcare · 6.16 +1.2% today

Isolated · not yet confirmedMarket checked 11 Sept, 15:55 GMT-4

Market read

Teladoc Health, Inc.'s current read is isolated; its market group is not confirming.

No new filing conclusion is available. 0 of 16 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 10 directly disclosed connections are confirming.

Company+1.2% todayVolume comparison unavailable
Market group0 of 16 activeCloud-Based Software · unavailable
Disclosed network0 of 8 confirmingNo filing-linked name is confirming now
What would change this read
  • TDOC's market-adjusted activity becomes unusual and at least one connected name confirms.

Invalidation: The isolated read changes if TDOC's group or a disclosed connection begins moving with it.

Watch this read

Research brief

The story so far

Healthcare · Health Information Services

No new filing conclusion is available. 0 of 16 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 10 directly disclosed connections are confirming.

Evidence that supports

No thresholded supportive filing evidence is available yet.

Evidence that challenges

No thresholded adverse filing evidence is available yet.

What would clarify the read
  • TDOC's market-adjusted activity becomes unusual and at least one connected name confirms.

Company research

Understand the business, not just the ticker

As of Sep 12, 2026
Business model and earnings drivers

Use the company’s filings to identify the few operating, demand, cost, capital and regulatory variables that determine its earnings power.

Key research questions
  • Which operating variable is changing?
  • Is that change durable, cyclical or one-off?
  • What evidence would disprove the current interpretation?
Annual periods9
Price observations320
Usable filing statements98
Verified relationships8
Evidence supporting the case
  • Operating margin changed +29.3 percentage points in the latest annual period.
  • Net margin changed +31.0 percentage points in the latest annual period.
Evidence challenging the case
  • Latest annual revenue changed -1.5% year over year.
  • Diluted shares increased 3.3% in the latest annual period.
  • Input and raw-material costs has repeated adverse evidence across 3 filings.
  • Labor availability and costs has repeated adverse evidence across 3 filings.
Questions before a position
  • EV/sales is 95% below the available filing-peer median; determine whether growth and quality justify the difference.
Longer-term price context

Price as of Sep 11, 2026

6.16
6m+19.3%12m-22.0%24m—
Annual trajectory

Reported annual revenue and per-share history. This is accounting history, not a forecast.

PeriodRevenueYoYDiluted EPSShare change
2021-12-31$2.0B+85.8%$-2.73—
2022-12-31$2.4B+18.4%$-84.60+2.9%
2023-12-31$2.6B+8.1%$-1.34+1.9%
2024-12-31$2.6B-1.3%$-5.87+3.6%
2025-12-31$2.5B-1.5%$-1.14+3.3%

What management says matters

Persistent and emerging business drivers

Restructuring and cost reductionsmixed · 4 filings
“As a result of our review of the business to drive further efficiency, better align resources, and improve profitability, we continue to expect to incur pre-tax restructuring costs under our plan in the range of $15.0 million to $20.0 million for the year end…”
10-Q · Apr 30, 2026 ↗
Input and raw-material costsnegative · 3 filings
“The increase was primarily driven by higher labor costs, technology costs, and amortization of devices, partially offset by lower provider costs.”
10-K · Feb 26, 2026 ↗
Labor availability and costsnegative · 3 filings
“The increase was primarily driven by higher labor costs, technology costs, and amortization of devices, partially offset by lower provider costs.”
10-K · Feb 26, 2026 ↗
Capital investment and capacitynegative · 1 filings
“The year-over-year decrease was substantially driven by an increase in capitalized software development costs, partially offset by a decrease in capital expenditures.”
10-K · Feb 26, 2026 ↗

Valuation discipline

Descriptive valuation snapshot

Price/sales 0.4× · EV/sales 0.1×. Comparisons use only industry-matched filing peers.

Scenario scaffold

Mechanical 2.0-year scenarios are available as editable assumptions, not consensus.

Price action

How the market is pricing the story

6.16+1.2% today

Jodie does not have enough daily observations to draw a useful short-term chart for this asset. The latest quoted price was checked 11 Sept, 15:55 GMT-4; this is a coverage limitation, not a flat-price conclusion.

Developments

No sourced recent-development timeline yet

Jodie has not returned a relevant primary source or news item for TDOC. This is an evidence-coverage gap, not a conclusion that nothing material happened.

Business and financial condition

Reported financial figures are not available yet

Jodie has not returned structured SEC XBRL fundamentals for this asset. This is a coverage limitation, not an assessment of the business or its financial health.

Filing analysis

No comparable filing assessment is available yet

Jodie has not yet found a suitable current-versus-prior filing comparison for TDOC. This does not mean the latest filing was neutral or immaterial.

Business ecosystem

The relationships behind TDOC

Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.

Depends on

AMWLFiling-linked namecompetitorFeb 26, 2026 ▾

“10 Table of Contents Integrated Care Segment Competitors in the virtual care market include MDLive (owned by Cigna), American Well Corporation, Included Health, and Accolade (owned by Transcarent), among other participants.”

AMZNAmazon.com, Inc.competitorFeb 26, 2026 ▾

“We also face competition from large health plans that in some cases have developed their own virtual care or chronic condition management tools, as well as large technology companies, such as Amazon, which have developed or acquired their own virtual care sol…”

Depended on by

OMDAOmada Health, Inc.competitorMay 8, 2026 ▾

“We currently face competition from a range of digital health companies, including direct competition from: competitors offering cardiometabolic programs, such as Hello Heart Inc., Lark Technologies, Inc., Livongo (via Teladoc Health, Inc.), Onduo LLC, Vida He…”

Filing peers

OMDACLOVDOCS

Companies whose filings use similar operating language.

Open the three relationships above to see Jodie’s filing proof. Pro unlocks 13 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →

What is moving around it

Live connections

TDOC is currently a Follower in the organic co-movement group Cloud-Based Software. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.

This group is retained as the last observed read for TDOC; it is not active in the latest market snapshot.

Context history

Theme membership history

No durable theme membership has been observed for this name yet.